The DCGI has issued show-cause notices to 20 epharmacies, including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in violation of the Drugs and Cosmetics Act, 1940.
The companies have been asked to explain why they should not face consequences for breaking the rules. The Drugs and Cosmetics Act of 1940 governs drug importation, manufacturing, and distribution in India. The DCGI stated in the notice that the sale, stock, exhibit, or offer for sale or distribution of drugs through online, internet, or other electronic platforms without a licence may have an impact on drug quality and pose a risk to public health due to potential drug misuse through self-medication and indiscriminate use of the drugs.
